User:Mr. Ibrahem/Laronidase

Laronidase, sold under the brand name Aldurazyme, is a medication used to treat mucopolysaccharidosis I. This includes Hurler syndrome and Hurler–Scheie syndrome, as well as Scheie syndrome with at least moderate symptoms. It is given by gradual injection into a vein.

Common side effects include headache, nausea, abdominal pain, rash, joint pain, flushing, fever, and pain at the site of injection. Other side effects may include allergic reactions. It is a recombinant form of the enzyme L-iduronidase. It works by replacing this missing enzyme.

Laronidase was approved form medical use in Europe and the United States in 2003. In the United Kingdom it costs the NHS about £3,600 every 4 weeks for a 10 kg child as of 2021. In the United States this amount costs about 8,000 USD.